Details of the Drug Combination

General Information of Drug Combination (ID: DCDUWH2)

Drug Combination Name

Ibutilide

Indication

Disease Entry	Status	REF
Chronic myelogenous leukemia	Investigative	[1]

High-throughput Screening Result

Testing Cell Line: KBM-7

Zero Interaction Potency (ZIP) Score: 32.75

Bliss Independence Score: 32.75

Loewe Additivity Score: 45.18

LHighest Single Agent (HSA) Score: 45.19

Molecular Interaction Atlas of This Drug Combination

Molecular Interaction Atlas (MIA)

Indication(s) of Ibutilide

Disease Entry	ICD 11	Status	REF
Atrial fibrillation	BC81.3	Approved	[2]

Ibutilide Interacts with 1 DTT Molecule(s)

DTT Name	DTT ID	UniProt ID	Mode of Action	REF
Potassium channel unspecific (KC)	TT1VOHK	NOUNIPROTAC	Modulator	[3]
------------------------------------------------------------------------------------

References

1	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7200).
3	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.